Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 1999

View Archived Issues

Oncolytics Biotech enters reovirus development agreement

Chiroscience announces discovery of novel bone gene

Company Profile: FGene

Phase II HCV trial of Maxamine Therapy initiated

Sepracor and UCB reach Zyrtec isomer licensing agreement

Company Profile: GenoPlex

Squalene synthase inhibitor BMS-184494 tested in humans; spotlight on squalene synthase inhibitors

Plant-based Novogen product increases HDL cholesterol

Suppression of NF-kappaB enhances antitumor activity of TNF-alpha and CPT-11 via increased apoptosis

Sonata launched in Germany

Licensing opportunity from Cornell Research Foundation: antidiabetic fagopyritols

Journal alert: neostigmine is effective in the treatment of acute colonic pseudo-obstruction

Merck researchers discover nonpeptide GnRH antagonist series

DGI BioTechnologies and Novo Nordisk sign collaboration

Anti-MRSA trinems designed at Merck & Co.

Ketone-based hematopoietic agents developed at Toray

Warner-Lambert synthesizes antibacterial substituted quinazoline-2,4-diones

Novel growth factor from GDNF-neurturin family identified by Washington U. researchers

Academic investigators describe new agent for BNCT

Preclinical study indicates potential of OGT-918 in treating complicated metabolic disorders

New PDE4 inhibitors with reduced emetogenic potential in the Kyowa Hakko pipeline

Beta agonist KUL-1248, a novel agent for facilitating stone discharge and suppressing colic

Roche exercises call option to redeem outstanding Genentech shares; company to remain independent

Structural Bioinformatics and DuPont announce strategic alliance

U. of Alberta designs new bis-benzimidazole anticancer agents

Study indicates potential of KRN-5500 in the treatment of leukemia and lymphoma

Repligen acquires additional capital for secretin trials in autism

Kissei presents binding profile and functional characterization of alpha1-adrenoceptor antagonist

Relenza receives approval in the E.U. for treatment of influenza

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...